PA AAP Let's Talk Series: Pediatric Vaccine for COVID-19: Update on the Vaccine for Kids 5-11 Years Old, Boosters, and Omicron 1.19.22
Pediatricians, Family Medicine Physicians, Residents, Nurse Practitioners, Nurses, Practice Staff
At the end of this session, participants will be able to:
· Describe the basic structure and results of the Pfizer COVID vaccine trial involving five- to eleven-year-old children
· Discuss the potential benefits of a third "booster" dose of COVID vaccine for different patient populations
· Describe the risks of myocarditis and other inflammatory syndromes associated with COVID infection, and possibly with COVID vaccines
· Compare the clinical characteristics of the emerging Omicron variant to earlier variants of the SARS-CoV-2 virus
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses
Paul A. Offit, MD, FAAP, Attending Physician, Division of Infectious Diseases; Director, Vaccine Education Center, The Children’s Hospital of Philadelphia; Maurice Hilleman Chair of Vaccinology, Perelman School of Medicine, The University of Pennsylvania
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients to disclose.
Accreditation and credit designation
In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and the Pennsylvania Chapter of the American Academy of Pediatrics. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh School designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.00 Attendance